Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000042687
JPRN-UMIN000042687
Recruiting
未知

Observational Study for Long-term Follow-up Survey After Carbon-Ion Radiotherapy - Observational Study for Long-term Follow-up Survey After Carbon-Ion Radiotherapy

ational Institute for Quantum and Radiological Science and Technology0 sites10,000 target enrollmentJanuary 1, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsocalized Carcinoma

Overview

Phase
未知
Intervention
Not specified
Conditions
ocalized Carcinoma
Sponsor
ational Institute for Quantum and Radiological Science and Technology
Enrollment
10000
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 1, 2021
End Date
March 31, 2031
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Institute for Quantum and Radiological Science and Technology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •atients who refused to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
The observational study for the long-term follow-up of the participants of the preceding study "Prevention of Type II Endoleak with Embolization of IMA Before Endovascular Aneurysm Repair"Abdominal aortic aneurysm
JPRN-UMIN000047713Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine86
Completed
Not Applicable
A Prospective Longitudinal Observational Study of Clinical Outcomes, Adverse Events, and Secondary Malignancies After Definitive Radiotherapy for Breast Cancer Patients
JPRN-UMIN000034530The University of Tokyo4,000
Recruiting
Not Applicable
EpiReg India
CTRI/2023/10/058462Eris Lifesciences Ltd
Not yet recruiting
Not Applicable
Is variations in sleep pattern responsible for Aamavata(Rheumatoid Arthritis)Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
CTRI/2021/02/030960All India Institute of Ayurveda
Active, not recruiting
Not Applicable
An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis - RESTORE™ SIntravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)MedDRA version: 9.0Level: LLTClassification code 10045365
EUCTR2005-004105-28-GRPDL BioPharma, Inc.300